TRIN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Trinity Capital Inc. (TRIN) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. The stock offers a high dividend yield of 13.1%, insider buying activity is strong, and analysts have positive ratings with price targets above the current price. While recent financial performance shows a decline in net income and EPS, the company's revenue is growing, and its dividend stability makes it attractive for long-term income-focused investors.
The MACD is positive and contracting, indicating a potential bullish trend. RSI is neutral at 47.701, and moving averages are converging, suggesting consolidation. The stock is trading near its pivot level of 15.687, with key resistance at 16.18 and support at 15.194.
Insider buying increased by 105.59% over the last month.
High dividend yield of 13.1% with a transition to monthly dividends, indicating growth potential.
Analysts have issued Buy ratings with price targets of $18 and $19, above the current price.
Recent $50 million investment in Cala Health's wearable tremor therapy demonstrates strategic growth initiatives.
Net income dropped by 13.95% YoY, and EPS declined by 29.17% YoY in Q4
Stock trend analysis indicates a potential -3.36% decline over the next month.
No recent Congress trading data available, which could indicate limited political or institutional interest.
In Q4 2025, revenue increased by 0.81% YoY to $82.77 million, but net income dropped by 13.95% YoY to $39.46 million. EPS also declined by 29.17% YoY to 0.51. Gross margin remained flat. While revenue growth is positive, declining profitability metrics are a concern.
Analysts are positive on TRIN. Clear Street initiated coverage with a Buy rating and an $18 price target, citing strong portfolio yields and dividend coverage. Citizens raised its price target to $19 from $17.50, highlighting resilient growth and diversification in the private capital industry.
